Reuters logo
BRIEF-Staidson Beijing BioPharmaceuticals to fully acquire biotechnology firm
August 23, 2017 / 1:08 AM / a month ago

BRIEF-Staidson Beijing BioPharmaceuticals to fully acquire biotechnology firm

Aug 23(Reuters) - Staidson Beijing BioPharmaceuticals Co Ltd

* Says it plans to use 70 million yuan to acquire remaining 40 percent stake in a Beijing-based biotechnology firm

* Says it will hold 100 percent stake in the biotechnology firm

Source text in Chinese: goo.gl/FCE39t

Further company coverage: (Beijing Headline News)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below